Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchPPEPPE (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   All Outcomes       

Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial

Jul 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Case -7% Improvement Relative Risk PPE  Solberg et al.  Prophylaxis  RCT Does PPE reduce COVID-19 infections? RCT 3,801 patients in Norway (February - April 2023) No significant difference in cases c19early.org Solberg et al., BMJ, July 2024 FavorsPPE Favorscontrol 0 0.5 1 1.5 2+
RCT 4,575 adults in Norway showing no significant difference in reported COVID-19 cases with surgical face mask use in public spaces.
The study reports lower risk of overall respiratory infections, however this may be due to reporting bias - many more patients did not report data in the intervention arm, and the intervention appeared to be much more successful in patients with the belief that masks reduce infection (Figure 2), i.e., patients in the mask group that believe masks work may be less likely to report failure of their belief.
In theory, if the missing data for intervention patients is more likely to show infection, imputation using the baseline predictors would adjust the odds ratio upward, however only mask belief shows a significant association with the outcome, and the analysis cannot distinguish between an actual association and reporting bias.
risk of case, 6.9% higher, RR 1.07, p = 0.82, treatment 21 of 1,834 (1.1%), control 21 of 1,967 (1.1%), odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Solberg et al., 24 Jul 2024, Randomized Controlled Trial, Norway, peer-reviewed, mean age 51.0, 8 authors, study period 10 February, 2023 - 27 April, 2023, trial NCT05690516 (history). Contact: runar.solberg@fhi.no.
This PaperPPEAll
Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial
Runar Barstad Solberg, Atle Fretheim, Ingeborg Hess Elgersma, Mette Fagernes, Bjørn Gunnar Iversen, Lars G Hemkens, Christopher James Rose, Petter Elstrøm
BMJ, doi:10.1136/bmj-2023-078918
OBJECTIVE To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period. DESIGN Pragmatic randomised superiority trial. SETTING Norway. PARTICIPANTS 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm. CONCLUSION Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask.
AUTHOR AFFILIATIONS Contributors: All authors conceived and designed the study. RS is the guarantor. PE performed the statistical analysis. RS and IHE independently verified the data and statistical analyses. CR supervised the statistical analysis and reporting. RS wrote the first draft of the manuscript. AF, IHE, MF, BGI, LGH, CR, and PE critically reviewed and commented on each draft of the manuscript and approved the final manuscript for submission. RS, AF, IHE, MF, BGI, LGH, CR, and PE were responsible for the decision to submit the manuscript. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. LGH's institution (RC2NB) was contracted by WHO for the development of study protocol templates to evaluate public health and social measures; LGH received travel support from WHO; no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This study was approved by the Regional Ethics Committee South East Norway (reference 36544). Data sharing: The final anonymised trial dataset and statistical codes will be freely available to the public through GitHub ( https://github. com/folkehelseinstituttet/2024-facemask-trial-bmj ). Transparency: The lead author (the manuscript's guarantor) affirms that the manuscript is an honest, accurate, and transparent account of RESEARCH RESEARCH the study being reported; that no important aspects of the..
References
Abaluck, Kwong, Styczynski, Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh, Science, doi:10.1126/science.abi9069
Bartoszko, Farooqi, Alhazzani, Loeb, Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials, Influenza Other Respir Viruses, doi:10.1111/irv.12745
Bundgaard, Bundgaard, Raaschou-Pedersen, Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial, Ann Intern Med, doi:10.7326/M20-6817
Chou, Dana, Major Update: Masks for Prevention of SARS-CoV-2 in Health Care and Community Settings-Final Update of a Living, Rapid Review, Ann Intern Med, doi:10.7326/M23-0570
Chu, Akl, Duda, Solo, Yaacoub et al., COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis, Lancet, doi:10.1016/S0140-6736(20)31142-9
Collins, Service, Gupta, N95 respirator and surgical mask effectiveness against respiratory viral illnesses in the healthcare setting: A systematic review and meta-analysis, J Am Coll Emerg Physicians Open, doi:10.1002/emp2.12582
Daniel, Zhang, Farewell, Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets, Biom J, doi:10.1002/bimj.201900297
Hirt, Janiaud, Hemkens, Randomized trials on nonpharmaceutical interventions for COVID-19: a scoping review, BMJ Evid Based Med, doi:10.1136/bmjebm-2021-111825
Jakobsen, Gluud, Wetterslev, Winkel, When and how should multiple imputation be used for handling missing data in randomised clinical trials -a practical guide with flowcharts, BMC Med Res Methodol, doi:10.1186/s12874-017-0442-1
Jefferson, Dooley, Ferroni, Physical interventions to interrupt or reduce the spread of respiratory viruses, Cochrane Database Syst Rev, doi:10.1002/14651858.CD006207.pub6
Karsli, Yilmaz, Kemancı, The effect of N95 respirators on vital parameters, PETCO2, among healthcare providers at the pandemic clinics, Ir J Med Sci, doi:10.1007/s11845-022-03013-x
Lipp, Edwards, Disposable surgical face masks for preventing surgical wound infection in clean surgery, Cochrane Database Syst Rev, doi:10.1002/14651858.CD002929.pub2
Ljjr, Simberkoff, Bessesen, ResPECT investigators. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial, JAMA, doi:10.1001/jama.2019.11645
Manski, Partial identification of probability distributions
Niph, Weekendly raport
Rowe, Canosa, Meslem, Rowe, Increased airborne transmission of COVID-19 with new variants, implications for health policies, Build Environ, doi:10.1016/j.buildenv.2022.109132
Rubin, Multiple imputation for nonresponse in surveys
Solberg, Fretheim, Elgersma, Statistical analysis plan: The effect of face mask wearing against respiratory tract infectionsa pragmatic randomised trial, Zenodo, doi:10.5281/zenodo.7984532
Solberg, Fretheim, Elgersma, Study protocol: The protective effect of face mask wearing against respiratory tract infections: a pragmatic randomized trial, Zenodo, doi:10.5281/zenodo.7648390
Solberg, Fretheim, Iversen, Blinded assessment of face-masks study results, doi:10.5281/zenodo.8089320
Talic, Shah, Wild, Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis, BMJ, doi:10.1136/bmj-2021-068302
White, Carpenter, Horton, A mean score method for sensitivity analysis to departures from the missing at random assumption in randomised trials, Stat Sin, doi:10.5705/ss.202016.0308
Who, COVID-19 DASHBOARD
Who, Coronavirus disease (COVID-19): Masks
DOI record: { "DOI": "10.1136/bmj-2023-078918", "ISSN": [ "1756-1833" ], "URL": "http://dx.doi.org/10.1136/bmj-2023-078918", "abstract": "<jats:title>Abstract</jats:title>\n <jats:sec>\n <jats:title>Objective</jats:title>\n <jats:p>To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Design</jats:title>\n <jats:p>Pragmatic randomised superiority trial.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Setting</jats:title>\n <jats:p>Norway.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Participants</jats:title>\n <jats:p>4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Interventions</jats:title>\n <jats:p>Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14 day period (mask wearing at home or work was not mentioned). Participants in the control arm were assigned to not wear a surgical face mask in public places.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Main outcome measures</jats:title>\n <jats:p>The primary outcome was self-reported respiratory symptoms consistent with a respiratory infection. Secondary outcomes included self-reported and registered covid-19 infection and self-reported sick leave.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Results</jats:title>\n <jats:p>Between 10 February 2023 and 27 April 2023, 4647 participants were randomised of whom 4575 (2788 women (60.9%); mean age 51.0 (standard deviation 15.0) years) were included in the intention-to-treat analysis: 2313 (50.6%) in the intervention arm and 2262 (49.4%) in the control arm. 163 events (8.9%) of self-reported symptoms consistent with respiratory infection were reported in the intervention arm and 239 (12.2%) in the control arm. The marginal odds ratio was 0.71 (95% confidence interval (CI) 0.58 to 0.87; P=0.001) favouring the face mask intervention. The absolute risk difference was −3.2% (95% CI −5.2% to −1.3%; P&lt;0.001). No statistically significant effect was found on self- reported (marginal odds ratio 1.07, 95% CI 0.58 to 1.98; P=0.82) or registered covid-19 infection (effect estimate and 95% CI not estimable owing to lack of events in the intervention arm). Self-reported sick leave was equally distributed between the intervention and control groups (marginal odds ratio 1.00, 0.81 to 1.22; P=0.97).</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Conclusion</jats:title>\n <jats:p>Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Trial registration</jats:title>\n <jats:p>\n ClinicalTrials.gov\n <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"NCT05690516\" ext-link-type=\"clintrialgov\">NCT05690516</jats:ext-link>\n .\n </jats:p>\n </jats:sec>", "accepted": { "date-parts": [ [ 2024, 5, 29 ] ] }, "alternative-id": [ "10.1136/bmj-2023-078918" ], "author": [ { "ORCID": "https://orcid.org/0009-0004-9843-0654", "affiliation": [], "authenticated-orcid": false, "family": "Solberg", "given": "Runar Barstad", "sequence": "first" }, { "affiliation": [], "family": "Fretheim", "given": "Atle", "sequence": "additional" }, { "affiliation": [], "family": "Elgersma", "given": "Ingeborg Hess", "sequence": "additional" }, { "affiliation": [], "family": "Fagernes", "given": "Mette", "sequence": "additional" }, { "affiliation": [], "family": "Iversen", "given": "Bjørn Gunnar", "sequence": "additional" }, { "affiliation": [], "family": "Hemkens", "given": "Lars G", "sequence": "additional" }, { "affiliation": [], "family": "Rose", "given": "Christopher James", "sequence": "additional" }, { "affiliation": [], "family": "Elstrøm", "given": "Petter", "sequence": "additional" } ], "clinical-trial-number": [ { "clinical-trial-number": "nct05690516", "registry": "10.18810/clinical-trials-gov" } ], "container-title": "BMJ", "container-title-short": "BMJ", "content-domain": { "crossmark-restriction": true, "domain": [ "bmj.com" ] }, "created": { "date-parts": [ [ 2024, 7, 25 ] ], "date-time": "2024-07-25T00:05:17Z", "timestamp": 1721865917000 }, "deposited": { "date-parts": [ [ 2024, 8, 28 ] ], "date-time": "2024-08-28T16:35:19Z", "timestamp": 1724862919000 }, "indexed": { "date-parts": [ [ 2025, 2, 21 ] ], "date-time": "2025-02-21T19:39:43Z", "timestamp": 1740166783840, "version": "3.37.3" }, "is-referenced-by-count": 8, "issued": { "date-parts": [ [ 2024, 7, 24 ] ] }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by-nc/4.0/", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 7, 24 ] ], "date-time": "2024-07-24T00:00:00Z", "timestamp": 1721779200000 } } ], "link": [ { "URL": "http://data.bmj.org/tdm/10.1136/bmj-2023-078918", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://syndication.highwire.org/content/doi/10.1136/bmj-2023-078918", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "239", "original-title": [], "page": "e078918", "prefix": "10.1136", "published": { "date-parts": [ [ 2024, 7, 24 ] ] }, "published-online": { "date-parts": [ [ 2024, 7, 24 ] ] }, "publisher": "BMJ", "reference": [ { "key": "2024082809350769000_386.jul24_15.e078918.1", "unstructured": "WHO. COVID-19 DASHBOARD 2023. https://covid19.who.int/." }, { "DOI": "10.1016/j.buildenv.2022.109132", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.2" }, { "DOI": "10.1136/bmj-2021-068302", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.3" }, { "DOI": "10.1136/bmjebm-2021-111825", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.4" }, { "DOI": "10.1016/S0140-6736(20)31142-9", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.5" }, { "DOI": "10.7326/M23-0570", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.6" }, { "DOI": "10.1002/14651858.CD006207.pub6", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.7" }, { "DOI": "10.5281/zenodo.7648390", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.8" }, { "DOI": "10.5281/zenodo.7984532", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.9" }, { "key": "2024082809350769000_386.jul24_15.e078918.10", "unstructured": "NIPH. Weekendly raport. NIPH; 2023. https://www.fhi.no/publ/statusrapporter/luftveisinfeksjoner/." }, { "key": "2024082809350769000_386.jul24_15.e078918.11", "unstructured": "WHO. Coronavirus disease (COVID-19): Masks. 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-masks." }, { "key": "2024082809350769000_386.jul24_15.e078918.12", "unstructured": "Oslo Uo. Nettskjema. https://nettskjema.no/?redirectTo=/user/form." }, { "key": "2024082809350769000_386.jul24_15.e078918.13", "unstructured": "Solberg RB Fretheim A Iversen BG . Blinded assessment of face-masks study results. 2023. doi/10.5281/zenodo.8089320." }, { "DOI": "10.1002/bimj.201900297", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.14" }, { "DOI": "10.1186/s12874-017-0442-1", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.15" }, { "key": "2024082809350769000_386.jul24_15.e078918.16", "unstructured": "Rubin DB . Multiple imputation for nonresponse in surveys. John Wiley & Sons, 2004." }, { "key": "2024082809350769000_386.jul24_15.e078918.17", "unstructured": "Manski CF . Partial identification of probability distributions. Springer, 2003." }, { "DOI": "10.5705/ss.202016.0308", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.18" }, { "DOI": "10.7326/M20-6817", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.19" }, { "DOI": "10.1126/science.abi9069", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.20" }, { "DOI": "10.1002/14651858.CD002929.pub2", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.21" }, { "DOI": "10.1007/s11845-022-03013-x", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.22" }, { "DOI": "10.1001/jama.2019.11645", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.23" }, { "DOI": "10.1111/irv.12745", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.24" }, { "DOI": "10.1002/emp2.12582", "doi-asserted-by": "publisher", "key": "2024082809350769000_386.jul24_15.e078918.25" } ], "reference-count": 25, "references-count": 25, "relation": {}, "resource": { "primary": { "URL": "https://www.bmj.com/lookup/doi/10.1136/bmj-2023-078918" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial", "type": "journal-article", "update-policy": "https://doi.org/10.1136/crossmarkpolicy", "updated-by": [ { "DOI": "10.1136/bmj.q1867", "label": "Correction", "source": "publisher", "type": "correction", "updated": { "date-parts": [ [ 2024, 8, 28 ] ], "date-time": "2024-08-28T00:00:00Z", "timestamp": 1724803200000 } } ] }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit